In-depth analysis of biotech, pharma, and the life sciences Award-winning journalism from some of the nation’s most trusted and well-connected reporters
Tag - biotechnology
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend
Sarepta Therapeutics said Thursday that it has temporarily stopped a clinical trial of its second-generation medicine for patients with a certain type of
In-depth analysis of biotech, pharma, and the life sciences Award-winning journalism from some of the nation’s most trusted and well-connected reporters
Roche reported negative results Thursday from a long-running clinical trial investigating an experimental antibody treatment in people born with an inherited
The odds that Amylyx Pharmaceuticals wins approval from the Food and Drug Administration for Albrioza, its treatment for ALS, have increased significantly over
Advisers to the Food and Drug Administration voted unanimously in favor of approving an investigational gene therapy from Bluebird Bio on Thursday, concluding
As Mirati Therapeutics waits for the Food and Drug Administration to complete a review of its KRAS-targeting lung cancer drug later this year, final results
A Cambridge, Mass., biotech company claims to have made a discovery that could rewrite biology textbooks. ProFound Therapeutics said Thursday that it had
DANA POINT, Calif. — Even the best treatment for a disease is no help if you can’t pinpoint the patients who need it. And a panel of experts this week grappled
